https://pipelinereview.com/Ambrx-to-receive-milestone-payment-from-Bristol-Myers-Squibb-for-the-initiation-of-Phase-1-Clinical-Trial-of-a-long-acting-Relaxin-derivative/
Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative